Müller F, Sinzig G
Z Hautkr. 1982 Jul 1;57(13):983-1001.
Reports on the significance in the demonstration of IgM class antibodies in congenital syphilis are contradictory. The reason for discrepant observations are of technical or biological source. In order to explain the several uncertainties, serum samples from 1031 newborns and infants of syphilitic mothers were investigated quantitatively with the IgM-FTA-ABS, the 19S (IgM)-FTA-ABS and cardiolipin CF test. If serum specimens of the mothers were available they were investigated in the same tests for treponema-specific 19S(IgM) class and antilipoidal antibodies. In the evaluation of the results, the history of infection and treatment of the mothers as well as clinical observations in the infants were considered. In 26 children a congenital acquired syphilis was strongly indicated by demonstration of treponema-specific 19S(IgM) class antibodies by the 19S(IgM)-FTA-ABS-Test and tae good agreement with the history of untreated mothers. In another 1005 infants a congenital infection by T. pallidum could be excluded by the non-reactive 19S(IgM)-FTA-ABS as well as clinical observations. Furthermore, immunological findings of three children who had acquired syphilis after birth are demonstrated before and after specific treatment. It could be shown that the 19S(IgM)-FTA-ABS is much more infaillable than the IgM-FTA-ABS as far as technical and biological uncertainties are concerned. Considering all possible errors and the results of re-investigations of IgM non-reactive infants of syphilitic mothers (up to one year after birth) it is demonstrated that congenital syphilis can be differentiated from passively transmitted 7S(IgG) class antibodies (of the mother) or 19S(IgM) class anti-antibodies (of the child) with a significance of about 99%. It is finally concluded that serological diagnosis of congenital syphilis should be started in the pregnant women. By making the diagnosis in pregnancy followed by adequate treatment, irreversible damages as well as so-called serological scars can be avoided in the children.
关于先天性梅毒中IgM类抗体检测意义的报道相互矛盾。观察结果存在差异的原因源于技术或生物学方面。为了解释这些不确定性,我们采用IgM - FTA - ABS、19S(IgM)- FTA - ABS和心磷脂补体结合试验对1031名梅毒母亲的新生儿和婴儿的血清样本进行了定量研究。如果有母亲的血清样本,也会对其进行相同检测,以检测梅毒螺旋体特异性19S(IgM)类抗体和抗脂质抗体。在评估结果时,考虑了母亲的感染和治疗史以及婴儿的临床观察情况。通过19S(IgM)- FTA - ABS试验检测到梅毒螺旋体特异性19S(IgM)类抗体,并与未治疗母亲的病史高度吻合,强烈提示26名儿童患有先天性获得性梅毒。另外1005名婴儿通过19S(IgM)- FTA - ABS检测呈阴性以及临床观察,排除了梅毒螺旋体先天性感染。此外,还展示了3名出生后感染梅毒的儿童在特异性治疗前后的免疫学检查结果。结果表明,就技术和生物学不确定性而言,19S(IgM)- FTA - ABS比IgM - FTA - ABS更可靠。考虑到所有可能的误差以及对梅毒母亲IgM阴性婴儿(出生后一年内)的重新检测结果,结果表明先天性梅毒与被动传递的7S(IgG)类抗体(来自母亲)或19S(IgM)类抗抗体(来自儿童)的区分具有约99%的显著性。最终得出结论,先天性梅毒的血清学诊断应在孕妇中开始。通过在孕期进行诊断并给予适当治疗,可以避免儿童出现不可逆转的损害以及所谓的血清学瘢痕。